NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research

In Special Recognition of the work of The Stand Up To Cancer-Lustgarten Foundation Pancreatic Dream Team and in honor of Pancreatic Cancer Awareness Month SEATTLE -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a new myeloid gene expression collaboration to expand the company's immuno-oncology portfolio. The [...]

BellBrook Labs Awarded NIH Grant to Validate New Target for Liver Fibrosis Using Transcreener GTPase Assay Platform

BellBrook Labs was awarded a Phase I Small Business Innovative Research (SBIR) grant of $353,000 from the National Institute on Alcohol Abuse and Alcoholism for pharmacological validation of GIV, a nonreceptor guanine nucleotide exchange factor (GEF), as a therapeutic target for liver fibrosis. BellBrook will use proprietary high throughput GTPase assay methods to identify small [...]

Irvine Scientific Introduces PRIME-XV® Mouse Hematopoietic Cell Basal Medium

Collaboration with Leading Stem Cell Researchers Results in Serum-free Medium for Mouse Hematopoietic Cell Culture SANTA ANA, California: Irvine Scientific, a world leader in the innovation and manufacture of cell culture media, announced today that a collaboration program with a leading stem-cell research facility in the USA, has resulted in a new, customized product for the [...]

QIAGEN’s GeneReader NGS System streamlines data management for labs

New middleware co-developed with Genohm ensures full chain of custody from Sample to Insight and integrates with most LIMS systems Hilden, Germany, and Charlotte, N.C. – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with lab informatics company Genohm to empower GeneReader NGS System users with seamless data management by integrating the [...]

QIAGEN GeneReader NGS System to relaunch in U.S. market

New improved chemistry for first Sample to Insight next-generation sequencing solution to be made available to first customers in December 2016 Charlotte, North Carolina, and Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the validation of new and improved sequencing  chemistry for its GeneReader NGS System, the world’s first complete [...]

Synthetic Genomics Appoints Tina Nova, Ph.D., and William McKee to Board of Directors

LA JOLLA, Calif. – Synthetic Genomics, Inc., announced today that it has appointed industry veterans Tina Nova, Ph.D., and William McKee to its board of directors. “Tina and Bill have decades of experience growing dynamic commercial organizations in new markets within the pharmaceutical and healthcare diagnostics industries,” said Oliver Fetzer, Ph.D., chief executive officer of Synthetic [...]

F-star Selects Genedata Biologics for Immuno-Oncology Therapeutics Discovery

Genedata Biologics™ implemented as an integrated workflow platform to increase throughput and automation of F-star’s bispecific discovery operations Basel, Switzerland and Cambridge, UK Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that F-star has licensed Genedata Biologics™ for use in their antibody discovery programmes. The platform [...]

TSI ANNOUNCES ACQUISITION OF MSP CORPORATION, A LEADER IN PRODUCTIVITY-ENHANCING INSTRUMENTATION

Shoreview, MN- TSI Incorporated, a global leader in precision instrumentation, today announced that it has acquired MSP Corporation (Shoreview, MN). MSP Corporation is an instrumentation and equipment company creating products for scientific research and industrial applications. They are known worldwide for their expertise in micro- and nano-particles and their creative use in research and manufacturing. MSP [...]

Fluidigm and GenomOncology Partner to Provide Automated Oncology NGS Library Preparation With Molecular Interpretation and Reporting

Empowering clinical research laboratories to achieve new levels of productivity SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced a distribution agreement to co-market the GO Clinical Workbench™ for molecular interpretation of somatic variants identified using Fluidigm systems. An elegant solution for clinical research laboratories seeking accuracy, flexibility, and scalability, this combined offering [...]

Horizon Discovery and CareDx Enter into OEM Agreement for Routine Inclusion of Cell-Free DNA Reference Standards in Transplant Testing

Agreement builds on existing collaboration to develop cell-free DNA (cfDNA) Reference Standards to support CareDx’s solid organ transplant injury monitoring tests Ongoing collaboration supports strategy to provide reliable revenue through the inclusion of Horizon’s HDxTM Reference Standards in established assay workflows Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application [...]

Access IBO on Knowledge Center